Investigational New Animal Drug (INAD)

An Investigational New Animal Drug (INAD) is a regulatory process that allows researchers to test new drugs or treatments on animals before they are approved for general use. It ensures the safety, effectiveness, and proper handling of the drug during clinical trials. The goal is to gather enough scientific data to determine if the medication is safe and beneficial for animals, while minimizing risks. The process is overseen by government agencies, such as the FDA in the U.S., which review trial plans to protect animal health and welfare throughout the development phase.